A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay.
Matthew L ChaseReid MerrymanDavid C FisherEric JacobsenAnn LaCasceCaron JacobsonArnold FreedmanMatthew S DavidsJennifer R BrownAllison JacobPhilippe ArmandJennifer CrombiePublished in: Leukemia & lymphoma (2020)